Eagle Pharmaceuticals became a publicly traded company on February 12, 2014.
Eagle Pharmaceuticals trades on the Nasdaq stock exchange with the ticker symbol “EGRX”.
Eagle Pharmaceuticals shares can be purchased from a registered broker or stock purchase service provider of your choice. Shares may not be purchased directly from Eagle Pharmaceuticals.
No, at this time the company does not pay a cash dividend.
BDO USA, LLP.
A transfer agent is a regulated organization that keeps track of stockholder records and information. Eagle Pharmaceuticals’ transfer agent is American Stock Transfer & Trust Company. Shareholders may contact American Stock Transfer & Trust Company at:
American Stock Transfer & Trust Company
6201 15th Avenue
Brooklyn, NY 11219
Shareholder inquiries: (718) 921-8124
Shareholder services: (800) 937-5449 Email shareholder services
If you hold your shares through a broker, you should contact that broker to discuss how to transfer your share ownership from that broker into the company’s books and records that are maintained by its transfer agent. We encourage shareholders to hold their shares through the transfer agent in “book entry” form, e.g., without any stock certificate. However, if you wish to receive a stock certificate, the transfer agent can issue one.
Please refer to the proxy statement that we will publish for information regarding the timing of our Annual Meeting of Stockholders.
You must be an Eagle Pharmaceuticals stockholder to attend the Annual Meeting of Stockholders. Additional information regarding attendance requirements will be detailed in the annual proxy statement.
Financial Reporting Information
Eagle Pharmaceuticals’ fiscal year end is December 31st.
All of Eagle Pharmaceuticals’ SEC filings can be found on our SEC filings page, on the SEC's public website at www.sec.gov, and at Edgar® Online®.
Please visit Eagle Pharmaceuticals’ Events & Presentations webpage to access upcoming and archived earnings calls.
You may contact Eagle’s Investor Relations firm, In-Site Communications, by phone at (212) 452-2793 or mail email@example.com.